Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS)

CNY 21.75

(0.05%)

EBITDA Summary of Vcanbio Cell & Gene Engineering Corp., Ltd

  • Vcanbio Cell & Gene Engineering Corp., Ltd's latest annual EBITDA in 2023 was 277.1 Million CNY , down -2.66% from previous year.
  • Vcanbio Cell & Gene Engineering Corp., Ltd's latest quarterly EBITDA in 2024 Q3 was 62.61 Million CNY , up 0.56% from previous quarter.
  • Vcanbio Cell & Gene Engineering Corp., Ltd reported an annual EBITDA of 321.19 Million CNY in 2022, down -24.36% from previous year.
  • Vcanbio Cell & Gene Engineering Corp., Ltd reported an annual EBITDA of 358.72 Million CNY in 2021, up 48.38% from previous year.
  • Vcanbio Cell & Gene Engineering Corp., Ltd reported a quarterly EBITDA of 62.61 Million CNY for 2024 Q3, up 0.56% from previous quarter.
  • Vcanbio Cell & Gene Engineering Corp., Ltd reported a quarterly EBITDA of 62.26 Million CNY for 2024 Q2, down 0.0% from previous quarter.

Annual EBITDA Chart of Vcanbio Cell & Gene Engineering Corp., Ltd (2023 - 1993)

Historical Annual EBITDA of Vcanbio Cell & Gene Engineering Corp., Ltd (2023 - 1993)

Year EBITDA EBITDA Growth
2023 277.1 Million CNY -2.66%
2022 321.19 Million CNY -24.36%
2021 358.72 Million CNY 48.38%
2020 53.78 Million CNY 0.75%
2019 277.11 Million CNY -41.68%
2018 261.93 Million CNY 272.38%
2017 192.65 Million CNY -26.27%
2016 157.1 Million CNY -41.72%
2015 332.4 Million CNY 134.78%
2014 97.2 Million CNY 81.31%
2013 68.96 Million CNY -10.82%
2012 79.53 Million CNY -0.75%
2011 85.27 Million CNY 11.59%
2010 70.62 Million CNY 85.9%
2009 41.5 Million CNY -64.13%
2008 102.54 Million CNY 48.23%
2007 60.38 Million CNY 72.1%
2006 46.38 Million CNY 139.67%
2005 29.61 Million CNY -150.77%
2004 -43.56 Million CNY -277.73%
2003 23.47 Million CNY 158.02%
2002 -41.74 Million CNY -260.39%
2001 25.22 Million CNY -61.63%
2000 65.74 Million CNY 1375.12%
1999 4.48 Million CNY -79.72%
1998 21.97 Million CNY -53.19%
1997 43.42 Million CNY 42.18%
1996 33.01 Million CNY 111.45%
1995 15.61 Million CNY -91.12%
1994 175.88 Million CNY 1123.35%
1993 14.37 Million CNY 0.0%

Peer EBITDA Comparison of Vcanbio Cell & Gene Engineering Corp., Ltd

Name EBITDA EBITDA Difference
Beijing Tiantan Biological Products Co., Ltd. 2.07 Billion CNY 86.615%
JiangSu WuZhong Pharmaceutical Development Co., Ltd. 51.04 Million CNY -442.909%
Jinyu Bio-technology Co., Ltd. 502.66 Million CNY 44.872%
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong 1.9 Billion CNY 85.423%
Zhejiang Ausun Pharmaceutical Co., Ltd. 339.62 Million CNY 18.409%
DaShenLin Pharmaceutical Group Co., Ltd. 3.59 Billion CNY 92.301%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. 1.65 Billion CNY 83.277%
GuiZhou SanLi Pharmaceutical Co.,Ltd 369.18 Million CNY 24.941%
Pulike Biological Engineering, Inc. 288.26 Million CNY 3.871%
Beijing Konruns Pharmaceutical Co.,Ltd. 188.49 Million CNY -47.012%
Shanghai Hile Bio-Technology Co., Ltd. 101.11 Million CNY -174.038%
Qingdao Vland Biotech INC. 217.9 Million CNY -27.171%
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. 379.57 Million CNY 26.996%
Aurisco Pharmaceutical Co.,Ltd. 414.37 Million CNY 33.127%
Zhejiang East Asia Pharmaceutical Co., Ltd. 253.19 Million CNY -9.446%
Hainan Huluwa Pharmaceutical Group Co., Ltd. 213.41 Million CNY -29.846%
Mabwell (Shanghai) Bioscience Co., Ltd. -929.77 Million CNY 129.804%
Beijing Hotgen Biotech Co., Ltd. 85.04 Million CNY -225.854%
Assure Tech (Hangzhou) Co., Ltd. 217.59 Million CNY -27.35%
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. 324.76 Million CNY 14.674%
Cabio Biotech (Wuhan) Co., Ltd. 152.91 Million CNY -81.21%
Shanghai Shen Lian Biomedical Corporation 99.74 Million CNY -177.82%
Nanjing Vazyme Biotech Co., Ltd. 156.12 Million CNY -77.49%
Shandong Kexing Bioproducts Co,.Ltd -119.68 Million CNY 331.539%
Shanghai Junshi Biosciences Co., Ltd. -2.15 Billion CNY 112.843%
Shanghai Model Organisms Center, Inc. 40.71 Million CNY -580.574%
Suzhou Zelgen Biopharmaceuticals Co., Ltd. -214.22 Million CNY 229.352%
Xiamen Amoytop Biotech Co., Ltd. 709.65 Million CNY 60.952%
Novogene Co., Ltd. 369.4 Million CNY 24.986%
Shanghai ZJ Bio-Tech Co., Ltd. -88.77 Million CNY 412.13%
Chengdu Olymvax Biopharmaceuticals Inc. 56.81 Million CNY -387.767%
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd 424.7 Million CNY 34.754%
Shanghai Haohai Biological Technology Co., Ltd. 712.95 Million CNY 61.133%
Jiangsu Bioperfectus Technologies Co., Ltd. -255.06 Million CNY 208.643%
Jiangsu Aidea Pharmaceutical Co., Ltd. -39.29 Million CNY 805.186%
Chengdu Easton Biopharmaceuticals Co., Ltd. 318.28 Million CNY 12.939%
Sinocelltech Group Limited -164.45 Million CNY 268.496%
Wuhan Keqian Biology Co.,Ltd 580 Million CNY 52.223%
Shanghai Allist Pharmaceuticals Co., Ltd. 696.61 Million CNY 60.221%
Anhui Huaheng Biotechnology Co., Ltd. 618.3 Million CNY 55.183%
Youcare Pharmaceutical Group Co., Ltd. 418.36 Million CNY 33.764%
Jiangsu gdk Biotechnology Co., Ltd. -54.8 Million CNY 605.637%
Beijing Kawin Technology Share-Holding Co., Ltd. 187.82 Million CNY -47.537%
Hangzhou Biotest Biotech Co.,Ltd. 146.45 Million CNY -89.212%